Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03871075 · ClinicalTrials.gov registry record · NA
Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease
A NA study of Peripheral Artery Disease, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 230
- Enrollment target
- 4
- Study locations
NCT03871075: Recruiting NA study of Peripheral Artery Disease, sponsored by Northwestern University.
NCT03871075 is a NA study of Peripheral Artery Disease that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 230 participants, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (89% higher). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03871075, a NA study of Peripheral Artery Disease, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
- 4
- Study locations
Study Summary
The INTERCEDE randomized trial will establish whether six-months of intermittent pneumatic compression combined with walking exercise improves walking endurance at six-month follow-up, compared to walking exercise + sham compression therapy, in people with lower extremity peripheral artery disease (PAD). The INTERCEDE trial will also determine whether intermittent pneumatic compression therapy improves walking endurance at 6-month follow-up, compared to a sham compression therapy. The trial will also determine whether benefits of intermittent pneumatic compression persist after intermittent pneumatic compression treatment is completed.
Primary Outcome
Among PAD participants, the investigators will determine whether intermittent pneumatic compression combined with exercise improves the 6-minute walk at 6-month follow-up compared to exercise alone.
Conditions Studied
Interventions
- BEHAVIORAL Health Education
- DEVICE Sham device
- DEVICE intermittent pneumatic compression
- BEHAVIORAL exercise
Study Locations (4)
Illinois
- Northwestern University - Chicago
- University of Chicago - Chicago
Michigan
- Henry Ford Health - Detroit
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT03871075 shows while recruiting
NCT03871075 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (89% higher).
The record links to 1 condition, with Peripheral Artery Disease appearing as the primary indexed condition, and to 4 interventions - of which Health Education is the first listed.
NCT03871075 reports a single indexed study location in Illinois, Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03871075 about?
NCT03871075 is a clinical study titled "Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease". The INTERCEDE randomized trial will establish whether six-months of intermittent pneumatic compression combined with walking exercise improves walking endurance at six-month follow-up, compared to walking exercise + sham compression therapy, in people with lower extremity peripheral artery disease (...
What is the current status of trial NCT03871075?
This trial is currently recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2019-01-02. Estimated completion is 2026-11.
What conditions does trial NCT03871075 study?
This clinical trial studies the following conditions: Peripheral Artery Disease.
What interventions are being tested in trial NCT03871075?
The interventions under investigation include: Health Education (BEHAVIORAL), Sham device (DEVICE), intermittent pneumatic compression (DEVICE), exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03871075?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03871075 being conducted?
This trial has 4 study locations across Illinois, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03871075's enrollment target sits among peer trials
230 9th of 50 higher than 42 of 50 other Peripheral Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI